Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-08-19

Clinical Trial Update: Prochlorperazine vs Imitrex for Acute Migraine in the Emergency Department [NA]

View source ↗

Summary

A clinical trial comparing prochlorperazine to sumatriptan (Imitrex) for acute migraine in the emergency department was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Imitrex (Sumatriptan)
  • prochlorperazine (prochlorperazine)

Snippet

Sponsor: United States Naval Medical Center, Portsmouth | Conditions: Acute Migraine Headache | NA | Status: WITHDRAWN